Engineers Gate Manager LP Fate Therapeutics Inc Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $51,909 - $123,952	31,460 Added 204.46%	46,847 $175,000
Q3 2023 Nov 14, 2023	SELL	$2.02 - $5.04 $46,849 - $116,892	-23,193 Reduced 60.12%	15,387 $32,000
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $183,640 - $254,242	38,580 New	38,580 $183,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $1.05 Million - $2.53 Million	106,039 Added 235.05%	151,152 $1.53 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $949,177 - $1.63 Million	45,113 New	45,113 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $484,540 - $1.16 Million	-27,252 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $808,566 - $1.64 Million	27,252 New	27,252 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $979,858 - $1.32 Million	-20,482 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $296,824 - $479,415	5,008 Added 32.36%	20,482 $1.21 Million
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $271,959 - $374,150	4,044 Added 35.38%	15,474 $1.34 Million
Q1 2021 May 17, 2021	BUY	$72.16 - $117.4 $824,788 - $1.34 Million	11,430 New	11,430 $942,000
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $264,306 - $700,492	-6,939 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$30.41 - $40.5 $102,877 - $137,011	-3,383 Reduced 32.77%	6,939 $277,000
Q2 2020 Aug 17, 2020	BUY	$20.21 - $35.23 $208,607 - $363,644	10,322 New	10,322 $354,000
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $248,357 - $384,500	-18,548 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.47 - $22.5 $115,220 - $167,580	7,448 Added 67.1%	18,548 $288,000
Q2 2019 Aug 14, 2019	BUY	$15.61 - $20.44 $173,271 - $226,884	11,100 New	11,100 $225,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$19.4 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$15.3 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$14.9 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$8.19 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$7.72 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $143M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account